The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre‐clinical study

Abstract Introduction Osteosarcoma is the most common primary malignancy of the bone. There is a lack of effective treatments for patients who experience relapsed osteosarcoma. One treatment for relapsed patients is gemcitabine and docetaxel combination chemotherapy (GEMDOX). This systematic review...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Kaan Low, Paola Foulkes, Frank Hills, Helen C. Roberts, Britta Stordal
Format:	Article
Language:	English
Published:	Wiley 2024-09-01
Subjects:	docetaxel gemcitabine relapsed osteosarcoma
Online Access:	https://doi.org/10.1002/cam4.70248